Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$118M |
| 2 |
JPMorgan Chase
JPM
|
+$87.7M |
| 3 |
Bank of America
BAC
|
+$66.7M |
| 4 |
Citigroup
C
|
+$58.3M |
| 5 |
Wells Fargo
WFC
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$227M |
| 2 |
Johnson & Johnson
JNJ
|
+$198M |
| 3 |
Coca-Cola
KO
|
+$184M |
| 4 |
PepsiCo
PEP
|
+$179M |
| 5 |
McDonald's
MCD
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.91% |
| 2 | Healthcare | 19.75% |
| 3 | Financials | 10.48% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
WEX
WEX
$6.31B
| $3.14M | 0.02% |
19,191
-43,706
| -69% | -$6.8M |
|
452
NetApp
NTAP
$37.2B
| $3.14M | 0.02% |
52,262
-175,270
| -77% | -$11.6M |
|
453
American Financial Group
AFG
$12.1B
| $3.13M | 0.02% |
22,820
+6,996
| +44% | +$959K |
|
454
Pricesmart
PSMT
$5.46B
| $3.13M | 0.02% |
51,534
-16,599
| -24% | -$1.08M |
|
455
Amgen
AMGN
$222B
| $3.11M | 0.02% |
11,827
+1,583
| +15% | +$424K |
|
456
Kilroy Realty
KRC
$4.42B
| $3.07M | 0.02% |
79,383
+3,920
| +5% | +$161K |
|
|
CMA
457
DELISTED
Comerica
CMA
| $3.06M | 0.02% |
45,724
+22,421
| +96% | +$1.55M |
|
458
Entergy
ETR
$50B
| $3.04M | 0.02% |
54,120
+27,180
| +101% | +$1.49M |
|
459
Sunrun
RUN
$2.46B
| $3.02M | 0.02% |
125,753
-4,967
| -4% | -$133K |
|
460
Bentley Systems
BSY
$10.6B
| $2.99M | 0.02% |
80,898
+47,195
| +140% | +$1.71M |
|
461
MGP Ingredients
MGPI
$375M
| $2.96M | 0.02% |
27,822
-9,865
| -26% | -$1.1M |
|
462
Glaukos
GKOS
$10.6B
| $2.95M | 0.02% |
67,609
-21,331
| -24% | -$1.05M |
|
463
Commerce Bancshares
CBSH
$8.5B
| $2.93M | 0.02% |
49,807
+14,263
| +40% | +$831K |
|
464
Freshpet
FRPT
$3.22B
| $2.92M | 0.02% |
55,377
-69,546
| -56% | -$4.14M |
|
465
MGIC Investment
MTG
$6.25B
| $2.92M | 0.02% |
224,455
+17,205
| +8% | +$226K |
|
466
West Pharmaceutical
WST
$24.9B
| $2.88M | 0.02% |
12,219
-29,858
| -71% | -$7.08M |
|
467
Steven Madden
SHOO
$3.55B
| $2.87M | 0.02% |
89,869
-79,289
| -47% | -$2.48M |
|
468
NXP Semiconductors
NXPI
$60.4B
| $2.84M | 0.02% |
17,948
-34,816
| -66% | -$5.52M |
|
469
CMS Energy
CMS
$22.3B
| $2.83M | 0.02% |
44,669
+18,189
| +69% | +$1.08M |
|
470
Teva Pharmaceuticals
TEVA
$41.2B
| $2.82M | 0.02% |
309,417
-134,841
| -30% | -$1.18M |
|
|
GTM
471
ZoomInfo Technologies
GTM
$1.22B
| $2.81M | 0.02% |
93,181
+73,786
| +380% | +$2.55M |
|
472
Western Alliance Bancorporation
WAL
$8.87B
| $2.8M | 0.02% |
46,969
+20,075
| +75% | +$1.3M |
|
473
US Foods
USFD
$24B
| $2.8M | 0.02% |
82,229
+29,447
| +56% | +$942K |
|
474
Ingles Markets
IMKTA
$1.67B
| $2.79M | 0.02% |
28,955
-9,385
| -24% | -$881K |
|
475
Boston Properties
BXP
$11.1B
| $2.77M | 0.02% |
40,963
-538
| -1% | -$38.1K |
|
Similar funds
Ray Dalio's Q4 2022 Portfolio in Review
As of Q4 2022, Ray Dalio held 953 positions worth $18.3B, down 7.3% from $19.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $3.25B in Q4 2022, closing 133 positions and reducing 457 holdings. Its most notable exit was Advanced Micro Devices, an estimated $45.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ray Dalio opened a new position in JPMorgan Chase worth $92.8M.
- Ray Dalio's largest Q4 2022 buy was JPMorgan Chase: 692,356 shares worth $92.8M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $118M increase.
- Ray Dalio's biggest Q4 2022 reduction was Procter & Gamble, cutting an estimated $227M.
- Ray Dalio fully exited Advanced Micro Devices in Q4 2022, selling an estimated $45.8M.
- Ray Dalio's ten largest holdings make up 32% of its $18.3B portfolio in Q4 2022.
- Ray Dalio opened 87 new positions and closed 133 in Q4 2022.
- Ray Dalio's portfolio value fell 7.3% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.